No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Flat for Week
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Moves to Buy: Rationale Behind the Upgrade
Ladenburg Thalmann Maintains Biodexa Pharmaceuticals(BDRX.US) With Buy Rating, Cuts Target Price to $18
Biodexa Pharmaceuticals Price Target Raised to $18 From $8 at Ladenburg
Biodexa Pharmaceuticals Adjusts Share Value Amid Drug Development Focus
Biodexa Pharmaceuticals Announces Result of General Meeting